Physician profile
Zane E Uhland
NPI 1518962323
$6,691.31
in general payments reported to CMS, 2019-2025
31 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $919 · 2021: $448 · 2022: $831 · 2023: $1,176 · 2024: $610 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,804.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,803.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,308.04 | 2022-2025 | Inspace, Mistral-Air, Omega |
| Zimmer Biomet Holdings, INC. | $1,324.57 | 2019-2023 | Tapestry |
| Trice Medical, INC. | $630.45 | 2019-2020 | |
| Pavmed INC. | $610.94 | 2021-2022 | |
| Bone Support INC. | $261.27 | 2019-2020 | |
| Ortho Development Corporation | $260.81 | 2023 | |
| Pacira Therapeutics, INC. | $164.34 | 2019-2021 | |
| Orthalign INC | $113.48 | 2022 | |
| Medacta USA, INC. | $108.96 | 2020 | |
| Organogenesis INC. | $104.95 | 2020-2021 | |
| Acera Surgical, INC. | $100.76 | 2023-2025 | Restrata Wound Matrix |
| Arcuro Medical INC | $90.22 | 2025 | Superball |
| Innovation Technologies INC | $65.61 | 2023 | Irrisept |
| Horizon Therapeutics Plc | $62.46 | 2020-2022 | |
| Bioventus LLC | $57.42 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $50.19 | 2024 | Biobrace 23mm |
| Osteomed LLC | $46.85 | 2019 | |
| Omnilife Science, INC | $43.33 | 2025 | |
| Abbott Laboratories | $35.50 | 2021 | |
| Smith+Nephew, INC. | $34.40 | 2021-2025 | Trigen Intertan |
| Grt US Holding, INC. | $25.59 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $25.00 | 2025 | Zilretta, Iovera |
| Scilex Pharmaceuticals INC. | $24.94 | 2019 | |
| Vericel Corporation | $23.98 | 2023 | Maci |
| Depuy Synthes Sales INC. | $22.58 | 2025 | Na |
| Nalu Medical, INC. | $21.04 | 2022 | |
| Amgen INC. | $16.36 | 2024 | Krystexxa |
| Collegium Pharmaceutical, INC. | $14.73 | 2019 | |
| Nevro Corp. | $14.47 | 2020 | |
| Orthofix Medical, INC. | $14.08 | 2021 | |
| Melinta Therapeutics, LLC | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Uhland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.